Memory loss in Focalin - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Memory loss, when it was recovered, drug effectiveness, race, and more among people who take Focalin (dexmethylphenidate hydrochloride). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Focalin?

Focalin has active ingredients of dexmethylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 4,781 Focalin users. Check the latest studies of Focalin.

What is Memory loss?

Memory loss is found to be associated with 2,728 drugs and 4,376 conditions by eHealthMe. Check the latest studies of Memory loss.

On Jul, 03, 2026

15 people who have Memory loss while taking Focalin were studied.

Severity of Memory loss *:

least: 7.69 %
moderate: 69.23 %
severe: 23.08 %
most severe: 0.0 %

When people recovered from Memory loss *:

while on drug: 0.0 %
after off the drug: 11.11 %
not yet: 88.89 %

Effectiveness of Focalin *:

not at all: 7.14 %
somewhat: 28.57 %
moderate: 50.0 %
high: 14.29 %
very high: 0.0 %

Race of the people *:

African American, Non-Hispanic: 8.33 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 0.0 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 91.67 %

Time on Focalin *:

Gender of people when taking Focalin *:

female: 66.67 %
male: 33.33 %

Age of people when taking Focalin *:

Conditions people have *:

Depression: 5 people, 33.33%
Fatigue (feeling of tiredness): 2 people, 13.33%
High Blood Pressure: 2 people, 13.33%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 13.33%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 6.67%
Arrhythmias (irregular heartbeat): 1 person, 6.67%
Back Pain - Low: 1 person, 6.67%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 6.67%
Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 1 person, 6.67%
Birth Control: 1 person, 6.67%

Other drugs people take besides Focalin *:

Xanax: 2 people, 13.33%
Vyvanse: 2 people, 13.33%
Bupropion Hydrochloride: 2 people, 13.33%
Celexa: 1 person, 6.67%
Fluoxetine Hydrochloride: 1 person, 6.67%
Fluoxetine: 1 person, 6.67%
Desmopressin Acetate Preservative Free: 1 person, 6.67%
Depakote Er: 1 person, 6.67%
Concerta: 1 person, 6.67%
Colace: 1 person, 6.67%

Other side effects people have besides Memory loss *:

Dizziness: 3 people, 20.00%
Anger: 2 people, 13.33%
Chronic Fatigue Syndrome (disorder that causes extreme fatigue): 2 people, 13.33%
Hair Loss: 2 people, 13.33%
Weight Decreased: 2 people, 13.33%
Weight Increased: 1 person, 6.67%
Depression: 1 person, 6.67%
Affect Lability (emotional incontinence): 1 person, 6.67%
Arrhythmias (irregular heartbeat): 1 person, 6.67%
Back Pain Aggravated: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Focalin and have Memory loss?

Check whether Memory loss is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Memory loss in Focalin

How the study uses the data?

The study is based on dexmethylphenidate hydrochloride (the active ingredients of Focalin). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.